Credit Suisse’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$5 3824
2022
Q4
$5 Sell
1
-124
-99% -$730 ﹤0.01% 3830
2022
Q3
$1K Buy
125
+115
+1,150% +$566 ﹤0.01% 3967
2022
Q2
$0 Buy
+10
New +$64 ﹤0.01% 4432

Other funds holding TGAN

Credit Suisse's TGAN Position: Q1 2023 in Review

Credit Suisse sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2023, closing a stake of 1 share — an estimated $5 sold.

Credit Suisse first reported a position in TGAN in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 39 funds tracked by Wall St. Rank hold TGAN as of Q1 2023.

  • Credit Suisse reported no remaining Transphorm, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1 Transphorm, Inc. Common Stock share in Q1 2023, an estimated $5.
  • Credit Suisse first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Credit Suisse's Transphorm, Inc. Common Stock position peaked at $1K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.